Presented ByDr Gianluca Ianiro, Agostino Gemelli University Policlinic, Italy
TrialPhase 2, TACITO ConferenceUEGW 2024
TypePeer-reviewed article
28 November 2024 11:19
Presented ByProf. Toni Choueiri, Dana-Farber Cancer Institute, MA, USA
TrialPhase 3, TiNivo-2 ConferenceESMO 2024
TypePeer-reviewed article
4 November 2024 11:52
Presented ByDr Chiara Ciccarese, Agostino Gemelli University Policlinic, Italy
TrialPhase 2, TACITO ConferenceESMO 2024
TypePeer-reviewed article
4 November 2024 11:44
TrialLITESPARK-005, SUNNIFORECAST
TypePeer-reviewed article
4 November 2024 11:42
TrialPhase 3, CLEAR, KEYNOTE-426, IMmotion010 ConferenceASCO 2024
TypePeer-reviewed article
18 July 2024 14:00
Presented ByProf. Laurence Albiges, Institut Gustave Roussy, France
TrialPhase 3, IMmotion010 ConferenceASCO 2024
13 June 2024 15:07
Presented ByDr Hedyeh Ebrahimi, Tehran University of Medical Sciences, Iran
TrialPhase 1 ConferenceASCO 2023
TypePeer-reviewed article
2 August 2023 09:11
Presented ByProf. Robert Motzer, Memorial Sloan Kettering Cancer Center, NY, USA
TrialPhase 3, CheckMate 914 ConferenceESMO 2022
TypePeer-reviewed article
17 November 2022 00:46
Presented ByProf Toni Choueiri, Dana-Farber Cancer Institute, MA, USA
TrialPhase 3, COSMIC-313 ConferenceESMO 2022
TypePeer-reviewed article
17 November 2022 00:41
Presented ByDr Axel Bex, The Royal Free London NHS Foundation Trust, UK
TrialPhase 3, IMmotion-010 ConferenceESMO 2022
TypePeer-reviewed article
17 November 2022 00:28
Presented ByProf. Thomas Powles, University of London, UK
TrialPhase 2, CALYPSO ConferenceASCO 2022
TypePeer-reviewed article
5 August 2022 14:18
Presented ByDr Christopher W. Ryan, Oregon Health & Science University, OR, USA
TrialPhase 3, EVEREST ConferenceASCO 2022
TypePeer-reviewed article
5 August 2022 14:14
Presented ByDr Axel Bex, Netherlands Cancer Institute, the Netherlands
TrialPhase 2, NeoAvAx ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:14
Presented ByDr Toni Choueiri, Dana-Farber Cancer Institute, MA, USA
TrialPhase 3, KEYNOTE-564 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:14
Presented ByDr Marc-Oliver Grimm, University Hospital Jena, Germany
TrialPhase 2, TITAN-RCC ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:13
Presented ByDr Matthew Zibelman, Fox Chase Cancer Center, PA, USA
TrialPhase 1/2 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:13
Presented ByDr Joseph Jacob, Upstate University Hospital, NY, USA
ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:13
Presented ByDr Rana McKay, University of California San Diego, CA, USA
ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:12
Presented ByDr Michael Atkins, Georgetown Lombardi Comprehensive Cancer Center, DC, USA
TrialPhase 2, HCRN GU16-260 ConferenceASCO GU 2022
TypePeer-reviewed article
8 April 2022 11:12
Presented ByDr Rachel Giles, Medicom
ConferenceASCO GU 2022
14 March 2022 07:21
Presented ByProf. Janet Brown, University of Sheffield, UK
TrialPhase 2, STAR ConferenceESMO 2021
TypePeer-reviewed article
19 November 2021 09:26
Presented ByDr Naveen Vasudev, St James University Hospital, UK
TrialPhase 2, PRISM ConferenceESMO 2021
TypePeer-reviewed article
19 November 2021 09:26
Presented ByProf. Arnulf Stenzl
ConferenceEAU 2021
31 August 2021 12:29
Presented ByDr Alberto Breda, Autonomous University of Barcelona, Spain
ConferenceEAU 2021
TypePeer-reviewed article
31 August 2021 12:28
Presented ByProf. Thomas Powles, Barts Cancer Centre, London, UK
TrialPhase 3, KEYNOTE-564 ConferenceEAU 2021
TypePeer-reviewed article
31 August 2021 12:28
Presented ByDr Arsalan Tariq , Royal Brisbane and Women's Hospital, Australia
ConferenceEAU 2021
TypePeer-reviewed article
31 August 2021 12:28
Presented ByDr Jonathan Thouvenin, Institut de Cancerologie Strasbourg Europe, France
ConferenceASCO GU 2021
TypePeer-reviewed article
24 March 2021 14:52
Presented ByDr Craig Gedye, Calvary Mater Newcastle, Australia
ConferenceASCO GU 2021
TypePeer-reviewed article
24 March 2021 14:52
Principal InvestigatorProf. Toni Choueiri, Dana Farber Cancer Institute, Harvard University, Boston, USA
TrialPhase 3, CheckMate 9ER ConferenceESMO Virtual Congress 2020
15 December 2020 15:49
Presented ByProf. Jens Bedke, University of Tübingen, Germany
TrialPhase 3, KEYNOTE-426 ConferenceEAU 2020
TypePeer-reviewed article
20 August 2020 10:41
Presented ByProf. Axel Bex & Prof. Antonio Finelli
TrialPhase 3, CARMENA; SURTIME ConferenceEAU 2020
TypePeer-reviewed article
20 August 2020 09:29
